glp 1 weight loss fda approved Wegovy Pill Wins Approval as First GLP-1 Oral Treatment for Obesity and FDA Approves Oral Semaglutide: First

Taking into account the considerable reduction in incretin effect (i.e., the secretion of insulin in response to oral glucose ingestion mediated by GLP-1 and glucose-dependent insulinotropic peptideGIP) in patients with T2DM and the significant anti-hyperglycemic action, GLP-1 RAs are strongly recommended in the management of patients with T2DM [13]

The dominant side effects of Qsymia are neurological (tingling, cognitive fog, insomnia) rather than gastrointestinal

These medications, often used for weight loss, may suppress appetite and slow digestion, which can limit B12 intake

For a good summary of some of the benefits and risks of GLP-1s for older adults, click here

Underlying Health Conditions: Health conditions that contribute to weight gain, such as hormonal imbalances or other medical issues, can complicate weight maintenance

It can also raise inflammation and lower a protein involved in controlling the amount of estrogen and testosterone actively present in the body